View in EDS

A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma.

Saved in:
Bibliographic Details
Title: A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma.
Authors: Hanna GJ; Department of Medical Oncology, Center for Head & Neck Oncology, Center for Salivary and Rare Head and Neck Cancers, Dana-Farber Cancer Institute, Boston, USA. Electronic address: glenn_hanna@dfci.harvard.edu., ONeill A; Department of Data Science, Dana-Farber Cancer Institute, Boston, USA., Cutler JM; Department of Medical Oncology, Center for Head & Neck Oncology, Center for Salivary and Rare Head and Neck Cancers, Dana-Farber Cancer Institute, Boston, USA., Flynn M; Department of Medical Oncology, Center for Head & Neck Oncology, Center for Salivary and Rare Head and Neck Cancers, Dana-Farber Cancer Institute, Boston, USA., Vijaykumar T; Center for Hematologic Oncology, Dana-Farber Cancer Institute, Boston, USA., Clark JR; Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, USA., Wirth LJ; Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, USA., Lorch JH; Department of Medical Oncology, Center for Head & Neck Oncology, Center for Salivary and Rare Head and Neck Cancers, Dana-Farber Cancer Institute, Boston, USA., Park JC; Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, USA., Mito JK; Department of Pathology, Brigham & Women's Hospital, Boston, USA., Lohr JG; Center for Hematologic Oncology, Dana-Farber Cancer Institute, Boston, USA., Kaufman J; Adenoid Cystic Carcinoma Research Foundation, USA., Burr NS; Adenoid Cystic Carcinoma Research Foundation, USA., Zon LI; Department of Stem Cell and Regenerative Biology, Boston Children's Hospital and Harvard Medical School, Boston, USA., Haddad RI; Department of Medical Oncology, Center for Head & Neck Oncology, Center for Salivary and Rare Head and Neck Cancers, Dana-Farber Cancer Institute, Boston, USA.
Source: Oral oncology [Oral Oncol] 2021 Aug; Vol. 119, pp. 105366. Date of Electronic Publication: 2021 Jun 03.
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9709118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0593 (Electronic) Linking ISSN: 13688375 NLM ISO Abbreviation: Oral Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34091189
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hanna+GJ%22">Hanna GJ</searchLink>; Department of Medical Oncology, Center for Head & Neck Oncology, Center for Salivary and Rare Head and Neck Cancers, Dana-Farber Cancer Institute, Boston, USA. Electronic address: glenn_hanna@dfci.harvard.edu.<br /><searchLink fieldCode="AU" term="%22ONeill+A%22">ONeill A</searchLink>; Department of Data Science, Dana-Farber Cancer Institute, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Cutler+JM%22">Cutler JM</searchLink>; Department of Medical Oncology, Center for Head & Neck Oncology, Center for Salivary and Rare Head and Neck Cancers, Dana-Farber Cancer Institute, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Flynn+M%22">Flynn M</searchLink>; Department of Medical Oncology, Center for Head & Neck Oncology, Center for Salivary and Rare Head and Neck Cancers, Dana-Farber Cancer Institute, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Vijaykumar+T%22">Vijaykumar T</searchLink>; Center for Hematologic Oncology, Dana-Farber Cancer Institute, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Clark+JR%22">Clark JR</searchLink>; Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Wirth+LJ%22">Wirth LJ</searchLink>; Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Lorch+JH%22">Lorch JH</searchLink>; Department of Medical Oncology, Center for Head & Neck Oncology, Center for Salivary and Rare Head and Neck Cancers, Dana-Farber Cancer Institute, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Park+JC%22">Park JC</searchLink>; Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Mito+JK%22">Mito JK</searchLink>; Department of Pathology, Brigham & Women's Hospital, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Lohr+JG%22">Lohr JG</searchLink>; Center for Hematologic Oncology, Dana-Farber Cancer Institute, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Kaufman+J%22">Kaufman J</searchLink>; Adenoid Cystic Carcinoma Research Foundation, USA.<br /><searchLink fieldCode="AU" term="%22Burr+NS%22">Burr NS</searchLink>; Adenoid Cystic Carcinoma Research Foundation, USA.<br /><searchLink fieldCode="AU" term="%22Zon+LI%22">Zon LI</searchLink>; Department of Stem Cell and Regenerative Biology, Boston Children's Hospital and Harvard Medical School, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Haddad+RI%22">Haddad RI</searchLink>; Department of Medical Oncology, Center for Head & Neck Oncology, Center for Salivary and Rare Head and Neck Cancers, Dana-Farber Cancer Institute, Boston, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229709118%22">Oral oncology</searchLink> [Oral Oncol] 2021 Aug; Vol. 119, pp. 105366. <i>Date of Electronic Publication: </i>2021 Jun 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9709118 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0593 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213688375%22">13688375 </searchLink><i>NLM ISO Abbreviation: </i>Oral Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34091189
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.oraloncology.2021.105366
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 105366
    Titles:
      – TitleFull: A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hanna GJ
      – PersonEntity:
          Name:
            NameFull: ONeill A
      – PersonEntity:
          Name:
            NameFull: Cutler JM
      – PersonEntity:
          Name:
            NameFull: Flynn M
      – PersonEntity:
          Name:
            NameFull: Vijaykumar T
      – PersonEntity:
          Name:
            NameFull: Clark JR
      – PersonEntity:
          Name:
            NameFull: Wirth LJ
      – PersonEntity:
          Name:
            NameFull: Lorch JH
      – PersonEntity:
          Name:
            NameFull: Park JC
      – PersonEntity:
          Name:
            NameFull: Mito JK
      – PersonEntity:
          Name:
            NameFull: Lohr JG
      – PersonEntity:
          Name:
            NameFull: Kaufman J
      – PersonEntity:
          Name:
            NameFull: Burr NS
      – PersonEntity:
          Name:
            NameFull: Zon LI
      – PersonEntity:
          Name:
            NameFull: Haddad RI
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2021 Aug
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1879-0593
          Numbering:
            – Type: volume
              Value: 119
          Titles:
            – TitleFull: Oral oncology
              Type: main
ResultId 1